ABSTRACT: Peripheral insulin resistance is the failure of proper cellular glucose uptake in response to insulin. Insulin resistance and hyperinsulinemia are associated with several disease states in the horse and reproductive function disturbances in humans, including polycystic ovarian syndrome. To test the hypothesis that insulin resistance (IR) and hyperinsulinemia disrupt the estrous cycle in mares, two experiments were conducted to first develop a model to induce IR and to then examine the effect of this model on the duration of the estrous cycle. In Exp. 1, a hyperinsulinemic-euglycemic clamp (HEC) procedure was performed on seven mares to determine insulin sensitivity before and immediately following infusion of a heparinized lipid solution. The HEC procedure was repeated 1 wk after lipid infusion. Mares developed IR following the lipid infusion (P < 0.05), and some individuals maintained
Introduction
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IR for up to 1 wk. Mares also exhibited increased blood insulin both immediately following treatment and 1 wk later (P < 0.05). In Exp. 2, induction of insulin resistance by lipid solution was not accompanied by changes in circulating concentrations of luteinizing hormone, and duration of the luteal phase, compared with the duration of untreated luteal phases. Nonetheless, lipid infusion and the resultant insulin resistance were associated with an increased interovulatory period (P < 0.05), and peak concentrations of progesterone (P < 0.05) were higher during the treated vs. untreated luteal phases of the estrous cycle. The results from the preliminary study suggest that infusion of a lipid solution may induce transient insulin resistance and hyperinsulinemia. The resulting insulin resistance and hyperinsulinemia may modify characteristics of the estrous cycle, perhaps at the level of the ovary.
The mechanisms that lead to disruption of the estrous cycle in obese mares remain to be elucidated; however, increased circulating concentrations of insulin disrupt gonadotropin secretion and consequently reproductive function in many species, including mice (Bruning et al., 2000) , pigs (Barb et al., 2001; Mao et al., 2001) , and sheep (Bucholtz et al., 2000) . In addition, in human females, polycystic ovarian syndrome, a reproductive state characterized by multiple anovulatory follicles (Pettigrew and Hamilton-Fairley, 1997) , is associated with insulin resistance and hyperinsulinemia (Nestler, 2000) .
There has been limited research on the role of obesity and insulin in the regulation of reproduction in mares. For this reason, the preliminary studies described in this paper were designed to test the hypothesis that transient insulin resistance and the resulting hyperinsulinemia disrupt the estrous cycle. To better understand the significance of insulin resistance in reproductive function in the mare, we developed a model for the induction of transient insulin resistance. This model is based on studies in several species, including humans, that demonstrated development of insulin resistance following an intravenous infusion of a heparinized lipid solution (Lee et al., 1988; Boden et al., 1995; Paolisso et al., 1995) .
Materials and Methods

Horses
Light horse mares (5 to 15 yr of age) were selected according to weight, lean body condition score (Henneke et al., 1983) , and low percentage of body fat as estimated using ultrasound of tailhead fat thickness (Kane et al., 1987) . The Institutional Animal Care and Use Committee approved all experimental procedures.
Experiment 1
Hyperinsulinemic-Euglycemic Clamp (HEC).
Owing to high repeatability (Soop et al., 2000) an HEC procedure, validated for the horse , was used to determine peripheral insulin sensitivity in all mares (n = 7, mean BW = 532 ± 51.41 kg; mean percentage of body fat = 13.1 ± 4.7%). Briefly, following a 12-h fast, circulating concentrations of glucose were determined at the beginning of the HEC procedure by use of a hand-held glucose meter (One Touch; Johnson and Johnson, New Brunswick, NJ). Hand-held meters were validated for use in the horse by demonstrating that blood glucose values were similar to those measured using a glucose auto-analyzer (YSI 3000 STAT Plus; Yellow Springs Instrument Co. Inc., Yellow Springs, OH). A bolus injection of insulin (0.4 mU/kg crystalline bovine insulin; Sigma-Aldrich, St. Louis, MO) was administered (i.v.) and followed immediately by a constant infusion of insulin (1.2 mUؒkg −1 ؒmin −1 ) for 120 min. Two minutes following the start of insulin infusion a 50% (wt/vol), dextrose solution was infused simultaneously (30 mL/min), and the infusion rate was adjusted to maintain euglycemia. Circulating concentrations of glucose were determined every 5 min throughout the period of infusion. As all mares maintained euglycemia within the 120-min period, the rate of glucose infusion during the final 30 min of the HEC procedure was used to determine insulin sensitivity.
Experimental Design. One week after the initial HEC procedure (control period), each mare was infused (i.v.) with a heparinized (0.2ؒIUؒkg −1 ؒmin −1 ) 20% (wt/vol) lipid emulsion (Liposyn II; Abbott Laboratories, North Chicago, IL) at a rate of 2 mL/min for 4 h. Concurrent with the start of the infusion, a 200-IU bolus of heparin was also administered to facilitate lipolysis into free fatty acids (Orme and Harris, 1997) . Immediately following lipid infusion, another HEC procedure was executed to determine insulin sensitivity (treatment period). To confirm the anticipated transient insulin resistant condition, an additional HEC procedure was performed 1 wk after infusion of the lipid solution (recovery period).
Collection of Blood Samples. Before each HEC procedure, blood samples were collected at 10-min intervals for 20 min before the HEC to determine physiological concentrations of insulin and glucose. Thereafter, blood samples were collected at 10-min intervals to determine concentrations of insulin. Additional blood samples were collected at 20-min intervals into evacuated tubes (Vacutainer Systems; Becton Dickson, Franklin, NJ) containing EDTA and used for determination of free fatty acids. Sampling for insulin and determination of free fatty acids occurred for 120 min, encompassing the duration of the HEC procedure. Blood samples were immediately centrifuged and the plasma harvested for subsequent determination of FFA concentrations or allowed to clot overnight at 4°C. The next day, blood samples were centrifuged at 1,900 × g and the serum harvested and stored frozen for subsequent analysis of insulin concentration.
Experiment 2
Experimental Design. Mares were selected at random from the general herd, and the HEC procedure was performed to determine insulin sensitivity. Mares that had a glucose infusion rate of greater than 100 mL/h were considered the most insulin sensitive and were therefore selected for the experiment (n = 7). All mares served as their own controls. Estrous cycles were synchronized (Loy et al., 1981) , and mares completed one control cycle (n = 7) approximately the first week of May. To decrease the duration of the experiment and thereby minimize the effects of environmental influences on insulin sensitivity, mares were administered prostaglandin F 2α to initiate premature luteolysis. During this "short cycling," mares again underwent an HEC the first week of June, to ensure sustained insulin sensitivity. Ovarian follicular development was determined at 2-to 3-d intervals by palpation per rectum and ultrasonography. On identification of an ovarian follicle of 30 mm or greater, each mare received a heparinized lipid infusion. This infusion occurred approximately 2 d (2.00 ± 1.5 d; n = 7) before ovulation. Immediately after cessation of the lipid infusion, an HEC was executed to confirm induced insulin resistance. An additional HEC was performed 1 wk later to determine duration of transient insulin resistance.
Collection of Blood Samples. During the estrous cycle, before and after lipid infusion, blood samples were collected three times per week (Monday, Wednesday, and Friday). Samples were subsequently assayed for concentrations of progesterone and LH. Changes in circulating concentrations of progesterone were used to identify the occurrence of ovulation, the interval between successive ovulations (interovulatory interval) and the duration of the luteal phase in each estrous cycle.
Hormone and FFA Determination
Circulating concentrations of insulin were determined by RIA (Coat-A-Count; Diagnostic Products Figure 1 . Changes in mean glucose infusion rates (±SEM; n = 7) during a hyperinsulinemic-euglycemic clamp procedure performed for the control (᭺), immediately following treatment (ᮀ), and recovery (᭹) periods for Exp. 1. The period immediately following treatment differed from both the control and recovery periods (P < 0.05).
Corp., Los Angeles, CA), as described elsewhere . Intra-and interassay CV of pooled samples were 3.8 and 11.0%, respectively (n = 5 assays). Detection limits for the insulin assays were approximately 2.19 IU/mL. Progesterone was determined using a RIA described previously (Silvia et al., 1992) . Intraand interassay CV of pooled samples were 2.9 and 6.1%, respectively (n = 4 assays). The limit for detection for the progesterone assay was 0.04 ng/mL. Concentrations of LH were determined by a double antibody RIA as described by Thompson et al. (1986) . Intra-and interassay CV for pooled samples were 4.46 and 18.7%, respectively (n = 4 assays). The detection limit of the LH assays was approximately 0.90 ng/mL. Free fatty acids were determined by an in vitro enzymatic colorimetric method using a nonesterified fatty acid kit (NEFA C; Wako Chemicals Inc., Richmond, VA) adapted to a Cobas Fera II, a semiautomated spectrophotometer (Eisemann et al., 1988) . Intra-and interassay CV on for the prepared pools were 2.3 and 6.9%, respectively. The detection limit for FFA analysis was 62.03 mol/L.
Statistical Analyses
Data are presented as means ± SEM. For Exp. 1, mean glucose infusion rates (GIR), and pre-HEC concentrations of insulin and free fatty acid were analyzed using repeated measures ANOVA employing the procedure of Satterthwaite for degrees of freedom using SAS (SAS Inst. Inc., Cary, NC). For Exp. 2, glucose infusion rates and concentrations of insulin were also evaluated using repeated measures ANOVA. Interovulatory intervals, luteal phase durations, peak and mean concentrations of progesterone, and mean concentrations of LH were compared between control and treated cycles by Student's paired t-test. In all instances with the use of the repeated measures ANOVA, time was the fixed effect, and the mares were the random effect; consequently, these were the only sources of variation in the model. There was no interaction specified in the model because there is only one fixed effect. The error term used to test the main effects was residual error.
Results
Experiment 1
Glucose Infusion Rates. As depicted in Figure 1 , there was a significant difference in glucose infusion rates between treatment periods (P < 0.05). Analysis of differences of least squares means indicated that changes were observed between the control and treatment HEC procedures (2.30 ± 0.29 mgؒkg −1 ؒmin −1 vs. 1.41 ± 0.25 mgؒkg −1 ؒmin −1 ; P < 0.05). Although lipid infusion significantly modified group insulin sensitivity, the GIR in one mare was greater than pretreatment values. Overall, mean glucose infusion rates did not differ between control and recovery periods (2.02 ± 0.54 vs. 2.29 ± 0.30 mgؒkg −1 ؒmin −1 ). However, 1 wk after infusion of the lipid solution, three of six mares that were previously identified as insulin resistant immediately following treatment were found to have maintained an insulin-resistant state compared with pretreatment. One mare that did not display decreased insulin sensitivity immediately following lipid treatment exhibited decreased insulin sensitivity 1 wk after treatment. Collectively, therefore, infusion of a heparinized lipid solution was accompanied by development of insulin resistance in all seven animals between 1 to 7 d after treatment.
Concentrations of Insulin. Concentrations of insulin
increased following treatment as illustrated in Figure  2 (P < 0.01). Mean concentrations of insulin tended to be higher for the treated vs. control period (10.11 ± 1.46 vs. 7.15 ± 2.73 IU/mL; P = 0.18). Circulating insulin values at the time of the recovery were markedly higher than pretreatment concentrations (18.78 ± 3.20 vs. 7.15 ± 2.73 IU/mL; P < 0.01).
Concentrations of Free Fatty Acids. Mean (± SEM)
concentrations of free fatty acids were significantly higher following treatment compared with control values (1.97 ± 0.24 vs. 0.57 ± 0.22 mmol/L; P < 0.001; Figure  3A) . However, at the time of the recovery period, HEC mean concentrations of free fatty acids did not differ from control values (0.61 ± 0.11 vs. 0.57 ± 0.22 mmol/ L). Mares that maintained decreased insulin sensitivity at the time of the recovery HEC also showed a decreased ability of insulin to stimulate FFA uptake, whereas mares that were sensitive at the time of the recovery showed an increased response to insulin ( Figure 3B ). Changes in mean concentrations of plasma FFA during Exp. 1 (n = 7). Panel A illustrates mean (±SEM) concentrations during the hyperinsulinemic-euglycemic clamp for the control (᭺), treatment (ᮀ), and recovery (᭹) periods. The treatment period differed from both the control and recovery periods (P < 0.001). Panel B illustrates concentrations of FFA in mares identified to be insulin sensitive (᭞, n = 2) or resistant (▲, n = 5) during the recovery period during Exp. 1.
Experiment 2
Glucose Infusion Rates. Glucose infusion rates for the control cycle, treated cycle preinfusion and treated cycle HEC 1 wk posttreatment were not different (Figure 4) . The control cycle, treated cycle pre-infusion, and 1 wk after heparinized lipid infusion glucose infusion rates were 2.04 ± 0.19 mgؒkg −1 ؒmin −1 , 2.12 ± 0.26 mgؒ kg −1 ؒmin −1 , and 2.10 ± 0.39 mgؒkg −1 ؒmin −1 respectively. However, as expected, the GIR immediately following treatment was lower than preinfusion values (1.49 ± 0.29 vs. 2.12 ± 0.26 mgؒkg −1 ؒmin −1 ; P < 0.05).
Concentrations of Insulin. Pre-HEC concentrations of
insulin were different following treatment with heparinized lipid (P < 0.05). However, this varied from the results observed in Exp. 1, in that the greatest increase in concentrations of insulin was observed immediately following treatment compared with control values (4.92 ± 0.90 vs. 3.53 ± 0.73 IU/mL) rather than at the time Figure 4 . Mean glucose infusion rates (±SEM) during the hyperinsulinemic-euglycemic clamp for the control cycle (᭹), treated cycle prelipid infusion (ᮀ), treated cycle immediately following treatment (᭺), and 1 wk following treatment (▲) for Exp. 2. Glucose infusion rates for the period immediately following treatment differed from the control period, the treated cycle preinfusion, and the period 1 wk following treatment (P < 0.05).
of the recovery. Circulating insulin values at the time of the recovery had decreased to control levels (3.15 ± 0.43 vs. 3.53 ± 0.73 IU/mL).
Duration of the Luteal Phase and Circulating Concentrations of Progesterone.
A trend toward a lengthened luteal phase was observed in the estrous cycle following infusion with a heparinized lipid solution compared with the untreated cycle. The duration of the luteal phase of the cycle was lengthened in three of seven mares after treatment compared with the control cycle (mean durations 19.57 ± 2.66 vs. 15.57 ± 0.97 d, P = 0.09, n = 7). However, of the seven treated estrous cycles, three displayed lengthened interovulatory intervals (IOI) compared with the control cycles and the mean duration of treated cycles was longer than control cycles (26.0 ± 2.41 vs. 20.29. ± 0.78 d, n = 7; P < 0.05).
Mean concentrations of progesterone are depicted in Figure 5 . There was no significant difference in mean concentrations of progesterone between treated and control cycle (7.46 ± 1.99 vs. 5.64 ± 1.39 ng/mL; n = 7). Also depicted in Figure 5 is peak progesterone during the luteal cycle. During the estrous cycles of treatment mares, significantly higher peak progesterone values were demonstrated compared with control cycles (12.87 ± 4.03 vs. 8.78 ± 2.23 ng/mL; n = 7; P < 0.05).
Luteinizing Hormone. Mean concentrations of LH did not differ for the duration of the estrous cycle that followed lipid infusion compared with the control cycle (3.95 ± 0.34 vs. 3.29 ± 0.13 ng/mL). Variation existed among mares as to differences in concentrations of LH between the control and treated cycles (Figure 6 ). One mare (Mare 59) exhibited a markedly higher rise in LH before ovulation during the cycle following treatment. Comparison of overall mean (±SEM) and peak concentrations of progesterone during the luteal phase of the estrous cycle for control (n = 7) and treated (n = 7) estrous cycles during Exp. 2. Mean concentrations of progesterone were not different. Means for each treatment group with different letters differ for peak concentrations (P < 0.05).
Discussion
The current study demonstrates that infusion of a heparinized lipid solution resulted in decreased insulin sensitivity in adult horses. In agreement with findings in other species (Boden et al., 1995; Paolisso et al., 1995) , development of insulin resistance was accompanied by reduced glucose infusion rates during the HEC procedure and increased insulin concentrations immediately preceding the HEC. However, the timing of the development of insulin resistance appeared variable because one mare displayed insulin resistance only after 7 d after treatment and not immediately after treatment. In human studies, a 3-to 4-h delay in the development of insulin resistance has been reported (Boden et al., 2001 ). To our knowledge, this is the first report in any species that the development of insulin resistance may occur several days after infusion of a lipid solution and, furthermore, that resistance may be sustained for 1 wk after treatment. An explanation for the latter observation is not forthcoming; however, it is unlikely that the maintenance of insulin resistance was caused by increased circulating concentrations of free fatty acids 1 wk after lipid infusion. At this time point, circulating concentrations of FFA were similar to control values. It has been suggested that in humans the timing of insulin resistance following infusion of lipids coincides with an increase in skeletal muscle hexo-phosphates, whereas there is a decrease of glucose-6-phosphate formation, indicating that the FFA effect on peripheral insulin action is through an increased flux of UDP-N-acetyl-hexosamines into the glucosamine pathway (Hawkins et al., 1997) . It is conceiv- Figure 6 . Luteinizing hormone profiles for the control (ᮀ, n = 7) and treated (᭹, n = 7) estrous cycles for Exp. 2. Luteinizing hormone was determined in blood samples collected every 2 to 3 d. The date of ovulation is designated time 0. Infusion of the lipid solution occurred 2 d before ovulation. able, therefore, that the maintenance of insulin resistance in some mares 1 wk after lipid infusion reflects maintenance of hexosamine end product build-up. An alternative explanation is that it might reflect differences in concentration of intramuscular triglyceride. The accumulation of intramuscular triglyceride varies among subjects and is independent of total body fat (Phillips et al., 1996) . It has been demonstrated that in fit men with similar body mass indexes, subjects with higher concentration of intramuscular triglycerides, more specifically intramyocellular lipid, had decreased whole-body glucose uptake in response to insulin (Virkamaki et al., 2001 ). These subjects also displayed an inability of insulin to decrease circulating concentrations of FFA, consistent with the response of the mares that maintained insulin resistance 1 wk following treatment with a lipid solution. Therefore, mares that are obese may not have high concentrations of intramuscular triglycerides, whereas mares in a lean body condition may have higher levels, thereby accounting for the lack of a consistent relationship between the body fat percentage and the maintenance of insulin resistance.
In several species, the model of induction of transient insulin resistance described in this study may provide an opportunity to investigate the association between insulin resistance and several disease states. In this regard, current animal models of insulin resistance demonstrate disturbances in cytokine and hormone production in association with insulin resistance. Conceivably, similar studies in the horse may provide new insight into the relationship between insulin resistance and the development of laminitis, osteochondrosis dessicans lesions, and other disorders. However, additional studies should be conducted to determine more specifically the duration of the induced insulin resistance.
Increased circulating concentrations of insulin have been shown to affect reproductive activity by modification of GnRH-mediated LH release (Bruning et al., 2000) , and also by direct affects on the ovary (DiamantiKandarakis and Bergiele, 2001; Mao et al., 2001 ). Experiment 2 was a preliminary study conducted to test the hypothesis that insulin resistance and associated hyperinsulinemia affect the estrous cycle in the mare. Following induction of insulin resistance by infusion of a heparinized lipid solution, the mean duration of luteal phase of the succeeding estrous cycle was marginally lengthened compared with the control cycle. Additionally, the time between successive ovulations following lipid infusion was lengthened significantly. The mechanisms that underlie the increased interval between successive ovulations are unknown, but it is likely to reflect a combination of a marginal increase in the duration of the luteal phase of the treatment estrous cycle, together with a nonsignificant increase in the duration of the follicular phase of the succeeding estrous cycle.
In human females, long-term insulin resistance and hyperinsulinemia is frequently associated with an increase in the duration of the follicular phase of the menstrual cycle and is particularly well documented in patients with polycystic ovarian syndrome. The mechanism by which this occurs may reflect an arrest of follicular development. Insulin can play a role in this phenomenon by enhancement of the effects of FSH on follicles that have acquired LH receptors. The prevailing hypothesis is that small follicles that have just attained LH receptors, in the presence of insulin, display enhanced estradiol production equal to mature follicles, thereby inhibiting further growth and arrest of the follicles in the immature stage (Diamanti- Kandarakis and Bergiele, 2001) . It is possible that some mares show longer follicular phases because follicular development has been slowed via this mechanism. In the current study, however, circulating concentrations of LH were not significantly different between the follicular and luteal phases of treated and untreated cycles. This latter observation might suggest that in the short-term any action by insulin is unlikely to involve a change in the hypothalamic-pituitary axis.
An alternative site of action by insulin might be the ovary. In this regard, hyperinsulinemia accompanied by increased steroid secretion by the ovary is observed in humans as noted in women with polycystic ovarian syndrome (Nestler, 2000) . Observations from Exp. 2 support these findings because concentrations of progesterone were slightly increased following treatment. Peak concentrations of progesterone were significantly higher during the cycle following treatment with FFA and development of insulin resistance compared with the control cycle. However, because samples were taken only three times per week, the values representing peak progesterone may not represent the true peak, as would have been detected by sampling daily. Because these studies were preliminary, it was determined to be sufficient to collect samples three times per week. Another explanation for the differences observed in concentrations of progesterone could be due to environmental conditions, such as photoperiod, varying from the control to treated cycle. However, the administration of prostaglandin F 2α to "short-cycle" the mares was employed to minimize these effects. The observation that insulin resistance and hyperinsulinemia was accompanied by increased steroid secretion by the ovary is consistent with observations made in other species. One such study was conducted in pigs. In gilts, feed restriction during follicular development depressed plasma progesterone; however, when animals were supplemented with insulin during feed restriction, the decreased concentrations of progesterone did not occur (Mao et al., 2001) . Another study conducted (Cox et al., 1994) found that estradiol was decreased in diabetic pigs. Similar to the findings of Exp. 2, there was no change in LH secretion, indicating that the absence of insulin decreased steroidogenesis. This observation in pigs and other species support the proposal that insulin exerts a stimulatory effect on progesterone production by the corpus luteum, and this effect is mediated by changes that occur in the developing follicle before ovulation.
Implications
Infusion of a heparinized lipid solution is a safe, reliable means for inducing insulin resistance and hyperinsulinemia in mares. The resulting hyperinsulinemia may modify follicular development and luteal function at the ovarian level rather than the hypothalamic pituitary level, as evidenced by no changes in luteinizing hormone. However, further studies are needed to determine whether a critical period exists in follicular development, during which increases in insulin are influential, and by what mechanism insulin exerts its effects. Finally, this model of inducting transient insulin resistance provides an opportunity to investigate the association between insulin resistance and many diseases. Current animal models of insulin resistance demonstrate cytokine and hormone production disturbances associated with insulin resistance. Similar studies in horses may provide insight into the relationship between insulin resistance and development of laminitis, osteochondrosis dessicans lesions, and other disorders.
